Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Drug Safety|January 22, 2003
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regionsRoberto Leone, Mauro Venegoni, Domenico Motola, et al.Drug Safety|February 15, 2023
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting SystemSalvatore Crisafulli, Paola Maria Cutroneo, Nicoletta Luxi, et al.Drug Safety|November 26, 2008
Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reportingMarco Tuccori, Francesco Lapi, Arianna Testi, et al.European Journal of Pediatrics|October 31, 2018
Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance databaseCarla Carnovale, Faizan Mahzar, Sara Scibelli, et al.Drug Safety|October 9, 2015
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO ProjectEmanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, et al.Frontiers in Public Health|March 7, 2025
Proximity care pathways and digitalization: opportunities and concerns for medication safety management-Insights from the ProSafe study on community perspectivesFrancesca Moretti, Maria Angela Mazzi, Sara Montresor, et al.Drug Safety|April 14, 2026
Sexual Dysfunction with Antipsychotics: Emerging Clues from a Disproportionality Analysis of the World Health Organization VigiBaseEfstathios Pavlidis, Spyridon Siafis, Elena Arzenton, et al.British Journal of Clinical Pharmacology|March 19, 2016
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in ItalyMonia Donati, Anita Conforti, Maria Carmela Lenti, et al.Frontiers in Drug Safety and Regulation|September 22, 2025
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunitiesSalvatore Crisafulli, Francesco Ciccimarra, Chiara Bellitto, et al.Drug Safety|September 2, 2011
Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reportingMarco Tuccori, Francesco Lapi, Arianna Testi, et al.Pageof 8